Marex Investors Urged to Seek Lead Role in Securities Suit Before Dec. 8 Deadline

Overview

• Competing plaintiff firms issued fresh notices on November 7–8 inviting Marex shareholders to move for lead‑plaintiff status by December 8, 2025.
• The pending class action covers purchases from May 16, 2024 through August 5, 2025 and alleges violations of Exchange Act §§10(b), 20(a) and SEC Rule 10b‑5.
• Complaints claim Marex sold over‑the‑counter financial instruments to itself and recorded inconsistent subsidiary and related‑party balances, including intercompany receivables and loans.
• Filings assert the company’s financial statements were unreliable and that investors were harmed when details became public.
• Notices state a lawsuit has been filed, no class has been certified, and investors may choose counsel, seek the lead role, or remain absent without upfront fees under contingency arrangements.